The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The global Blood Product market was valued at US$ 28320 million in 2023 and is anticipated to reach US$ 47570 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
Report Scope
The Blood Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- Shanghai RAAS
- China Biologic Products
- Hualan Biological Engineering Inc.
- Beijing Tiantan Biological Products Corp
- Pacific Shuanglin
- Boya Bio-Pharmaceutical
- Paisi Feike Biology Pharmacy Co., Ltd.
- Xinjiang Deyuan Bioengineering
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Shenzhen Weiguang
- Shanxi Kangbao
- Nanyue Biopharming Corporation Ltd
Segment by Type
- Albumin
- Immunoglobulin
- Clotting Factor
- Others
Segment by Application
- Bleeding Wound
- Immunodeficiency
- HBV
- Tetanus
- Rabies
- Hemophilia
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Product Market Perspective (2019-2030)
2.2 Blood Product Growth Trends by Region
2.2.1 Global Blood Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Product Historic Market Size by Region (2019-2024)
2.2.3 Blood Product Forecasted Market Size by Region (2025-2030)
2.3 Blood Product Market Dynamics
2.3.1 Blood Product Industry Trends
2.3.2 Blood Product Market Drivers
2.3.3 Blood Product Market Challenges
2.3.4 Blood Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Product Players by Revenue
3.1.1 Global Top Blood Product Players by Revenue (2019-2024)
3.1.2 Global Blood Product Revenue Market Share by Players (2019-2024)
3.2 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Product Revenue
3.4 Global Blood Product Market Concentration Ratio
3.4.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Product Revenue in 2023
3.5 Blood Product Key Players Head office and Area Served
3.6 Key Players Blood Product Product Solution and Service
3.7 Date of Enter into Blood Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Product Breakdown Data by Type
4.1 Global Blood Product Historic Market Size by Type (2019-2024)
4.2 Global Blood Product Forecasted Market Size by Type (2025-2030)
5 Blood Product Breakdown Data by Application
5.1 Global Blood Product Historic Market Size by Application (2019-2024)
5.2 Global Blood Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Product Market Size (2019-2030)
6.2 North America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Product Market Size by Country (2019-2024)
6.4 North America Blood Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Product Market Size (2019-2030)
7.2 Europe Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Product Market Size by Country (2019-2024)
7.4 Europe Blood Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Product Market Size (2019-2030)
8.2 Asia-Pacific Blood Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Product Market Size (2019-2030)
9.2 Latin America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Product Market Size by Country (2019-2024)
9.4 Latin America Blood Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Product Market Size (2019-2030)
10.2 Middle East & Africa Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Product Introduction
11.1.4 Takeda Revenue in Blood Product Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Blood Product Introduction
11.2.4 CSL Revenue in Blood Product Business (2019-2024)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Product Introduction
11.3.4 Grifols Revenue in Blood Product Business (2019-2024)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Product Introduction
11.4.4 Octapharma Revenue in Blood Product Business (2019-2024)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Product Introduction
11.5.4 Kedrion Revenue in Blood Product Business (2019-2024)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Product Introduction
11.6.4 LFB Group Revenue in Blood Product Business (2019-2024)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Product Introduction
11.7.4 Biotest Revenue in Blood Product Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Blood Product Introduction
11.8.4 BPL Revenue in Blood Product Business (2019-2024)
11.8.5 BPL Recent Development
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Detail
11.9.2 Shanghai RAAS Business Overview
11.9.3 Shanghai RAAS Blood Product Introduction
11.9.4 Shanghai RAAS Revenue in Blood Product Business (2019-2024)
11.9.5 Shanghai RAAS Recent Development
11.10 China Biologic Products
11.10.1 China Biologic Products Company Detail
11.10.2 China Biologic Products Business Overview
11.10.3 China Biologic Products Blood Product Introduction
11.10.4 China Biologic Products Revenue in Blood Product Business (2019-2024)
11.10.5 China Biologic Products Recent Development
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Detail
11.11.2 Hualan Biological Engineering Inc. Business Overview
11.11.3 Hualan Biological Engineering Inc. Blood Product Introduction
11.11.4 Hualan Biological Engineering Inc. Revenue in Blood Product Business (2019-2024)
11.11.5 Hualan Biological Engineering Inc. Recent Development
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Detail
11.12.2 Beijing Tiantan Biological Products Corp Business Overview
11.12.3 Beijing Tiantan Biological Products Corp Blood Product Introduction
11.12.4 Beijing Tiantan Biological Products Corp Revenue in Blood Product Business (2019-2024)
11.12.5 Beijing Tiantan Biological Products Corp Recent Development
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Detail
11.13.2 Pacific Shuanglin Business Overview
11.13.3 Pacific Shuanglin Blood Product Introduction
11.13.4 Pacific Shuanglin Revenue in Blood Product Business (2019-2024)
11.13.5 Pacific Shuanglin Recent Development
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Detail
11.14.2 Boya Bio-Pharmaceutical Business Overview
11.14.3 Boya Bio-Pharmaceutical Blood Product Introduction
11.14.4 Boya Bio-Pharmaceutical Revenue in Blood Product Business (2019-2024)
11.14.5 Boya Bio-Pharmaceutical Recent Development
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Detail
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Introduction
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Detail
11.16.2 Xinjiang Deyuan Bioengineering Business Overview
11.16.3 Xinjiang Deyuan Bioengineering Blood Product Introduction
11.16.4 Xinjiang Deyuan Bioengineering Revenue in Blood Product Business (2019-2024)
11.16.5 Xinjiang Deyuan Bioengineering Recent Development
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Detail
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Introduction
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Detail
11.18.2 Shenzhen Weiguang Business Overview
11.18.3 Shenzhen Weiguang Blood Product Introduction
11.18.4 Shenzhen Weiguang Revenue in Blood Product Business (2019-2024)
11.18.5 Shenzhen Weiguang Recent Development
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Detail
11.19.2 Shanxi Kangbao Business Overview
11.19.3 Shanxi Kangbao Blood Product Introduction
11.19.4 Shanxi Kangbao Revenue in Blood Product Business (2019-2024)
11.19.5 Shanxi Kangbao Recent Development
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Detail
11.20.2 Nanyue Biopharming Corporation Ltd Business Overview
11.20.3 Nanyue Biopharming Corporation Ltd Blood Product Introduction
11.20.4 Nanyue Biopharming Corporation Ltd Revenue in Blood Product Business (2019-2024)
11.20.5 Nanyue Biopharming Corporation Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
